Investor Presentaiton

Health - FY22 Snapshot ~1,550 Workforce 18% Pharmaceutical Industry Solutions 45 45 -14% / 0% Organic / Acquisitive Growth 17% EBITDA % $154M New Contract Signings $707M Backlog 4% In-store Health Clinics $167M 2022 Revenues Note: % may not add up due to rounding 78% Healthcare Professional Services REVENUE SEGMENTATION Customers Geography Offering ~42% Commercial ~5% International 0% Products -58% Government ~95% 100% Canada Services The majority of revenues are generated from Healthcare Professional Services 40 YEARS OF CALIAN

View entire presentation